These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Exertional hyperpyrexia: case report and review of pathophysiological mechanisms. Jarmulowicz MR; Buchanan JD J R Nav Med Serv; 1988; 74(1):33-8. PubMed ID: 3066900 [No Abstract] [Full Text] [Related]
43. Malignant hyperthermia: the clinical syndrome. Ranklev-Twetman E Acta Anaesthesiol Belg; 1990; 41(2):79-82. PubMed ID: 2371808 [TBL] [Abstract][Full Text] [Related]
44. Malignant hyperthermia following systemic rewarming after hypothermic cardiopulmonary bypass. Lichtman AD; Oribabor C Anesth Analg; 2006 Feb; 102(2):372-5. PubMed ID: 16428525 [TBL] [Abstract][Full Text] [Related]
45. Heat illness and soldiers. Porter AM Mil Med; 1993 Sep; 158(9):606-9. PubMed ID: 8232999 [TBL] [Abstract][Full Text] [Related]
46. A noninvasive investigation of muscle energetics supports similarities between exertional heat stroke and malignant hyperthermia. Bendahan D; Kozak-Ribbens G; Confort-Gouny S; Ghattas B; Figarella-Branger D; Aubert M; Cozzone PJ Anesth Analg; 2001 Sep; 93(3):683-9. PubMed ID: 11524341 [TBL] [Abstract][Full Text] [Related]
47. Fatal thermal injury. Denborough M Med J Aust; 1989 May; 150(10):608. PubMed ID: 2716576 [No Abstract] [Full Text] [Related]
49. Exertional heatstroke. Amundson DE; Summa RA Mil Med; 1992 Dec; 157(12):A6. PubMed ID: 1470363 [No Abstract] [Full Text] [Related]
50. [In vitro diagnosis of malignant hyperpyrexia syndrome]. Eldar I; Goldberg G; Glauber V; Perel A Harefuah; 1991 Dec; 121(12):499-502. PubMed ID: 1794753 [TBL] [Abstract][Full Text] [Related]
51. Occurrence of malignant hyperpyrexia in a patient with osteogenesis imperfecta. Rampton AJ; Kelly DA; Shanahan EC; Ingram GS Br J Anaesth; 1984 Dec; 56(12):1443-6. PubMed ID: 6498054 [TBL] [Abstract][Full Text] [Related]
52. Predisposing risk factors on susceptibility to exertional heat illness: clinical decision-making considerations. Cleary M J Sport Rehabil; 2007 Aug; 16(3):204-14. PubMed ID: 17923726 [TBL] [Abstract][Full Text] [Related]
53. Thermoregulatory responses to cooling in patients susceptible to malignant hyperpyrexia. Ayling JH; Ellis FR; Halsall PJ; Currie S Br J Anaesth; 1985 Oct; 57(10):983-90. PubMed ID: 4041325 [TBL] [Abstract][Full Text] [Related]
54. Malignant hyperpyrexia and isoflurane. A case report. Thomas DW; Dev VJ; Whitehead MJ Br J Anaesth; 1987 Sep; 59(9):1196-8. PubMed ID: 3663443 [TBL] [Abstract][Full Text] [Related]
55. Effect of diltiazem on porcine malignant hyperpyrexia induced by suxamethonium and halothane. Foster PS; Hopkinson KC; Denborough MA Br J Anaesth; 1989 May; 62(5):560-5. PubMed ID: 2730829 [TBL] [Abstract][Full Text] [Related]
56. Malignant hyperpyrexia in a serving officer. Bell G; deMello W J R Army Med Corps; 1996 Feb; 142(1):30-1. PubMed ID: 8667327 [No Abstract] [Full Text] [Related]
57. Obesity and the occurrence of heat disorders. Chung NK; Pin CH Mil Med; 1996 Dec; 161(12):739-42. PubMed ID: 8990832 [TBL] [Abstract][Full Text] [Related]
58. A complicated case of exertional heat stroke in a military setting with persistent elevation of creatine phosphokinase. Brown J; Mitchell S Mil Med; 1992 Feb; 157(2):101-3. PubMed ID: 1603384 [TBL] [Abstract][Full Text] [Related]